For: |
Yu Q, Zhou CX, Chen NS, Zheng SD, Shen LM, Zhang JK. A polymorphism within |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i4/383.htm |
Number | Citing Articles |
1 |
Chunxiao Zhou, Qiang Yu, Lei Chen, Jian Wang, Shudan Zheng, Jinkun Zhang. A miR-1231 binding site polymorphism in the 3′UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibility. Gene 2012; 507(1): 95 doi: 10.1016/j.gene.2012.06.073
|
2 |
Jie Sun, Haiqi Lu, Xian Wang, Hongchuan Jin, H. Grønbæk, M. Ladekarl, P.-D. Line, P. Stål. MicroRNAs in Hepatocellular Carcinoma: Regulation, Function, and Clinical Implications. The Scientific World Journal 2013; 2013(1) doi: 10.1155/2013/924206
|
3 |
Yanhong Qu, Honghong Qu, Manli Luo, Peng Wang, Chunhua Song, Kaijuan Wang, Jianying Zhang, Liping Dai. MicroRNAs related polymorphisms and genetic susceptibility to esophageal squamous cell carcinoma. Molecular Genetics and Genomics 2014; 289(6): 1123 doi: 10.1007/s00438-014-0873-x
|
4 |
Matthew F. Buas, Lynn Onstad, David M. Levine, Harvey A. Risch, Wong-Ho Chow, Geoffrey Liu, Rebecca C. Fitzgerald, Leslie Bernstein, Weimin Ye, Nigel C. Bird, Yvonne Romero, Alan G. Casson, Douglas A. Corley, Nicholas J. Shaheen, Anna H. Wu, Marilie D. Gammon, Brian J. Reid, Laura J. Hardie, Ulrike Peters, David C. Whiteman, Thomas L. Vaughan, Xiaoping Miao. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium. PLOS ONE 2015; 10(6): e0128617 doi: 10.1371/journal.pone.0128617
|
5 |
Ahmad M. Zidan, Eman A. Saad, Nasser E. Ibrahim, Medhat H. Hashem, Amal Mahmoud, Alaa A. Hemeida. Host pharmacogenetic factors that may affect liver neoplasm incidence upon using direct-acting antivirals for treating hepatitis C infection. Heliyon 2021; 7(5): e06908 doi: 10.1016/j.heliyon.2021.e06908
|
6 |
Yao Liu, Qun Zhou, Xiao-Shun He, Li-Ming Song, Lin Chen, Wei-Juan Jiao, Tong Shen, Su Yao, Hua Wu, Zhi-Bin Hu, Tian-Ming Gao, Jian-Ming Li. Genetic variants in ERBB4 is associated with chronic hepatitis B virus infection. Oncotarget 2016; 7(4): 4981 doi: 10.18632/oncotarget.6650
|
7 |
Song He, De-Chun Zhang, Cheng Wei. MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis. Clinics and Research in Hepatology and Gastroenterology 2015; 39(4): 426 doi: 10.1016/j.clinre.2015.01.006
|
8 |
Qiang Yu, Chunxiao Zhou, Jian Wang, Lei Chen, Shudan Zheng, Jinkun Zhang. A Functional Insertion/Deletion Polymorphism in the Promoter of PDCD6IP Is Associated with the Susceptibility of Hepatocellular Carcinoma in a Chinese Population. DNA and Cell Biology 2013; 32(8): 451 doi: 10.1089/dna.2013.2061
|
9 |
Lila E. Mullany, Roger K. Wolff, Jennifer S. Herrick, Matthew F. Buas, Martha L. Slattery, Geraldo A Passos. SNP Regulation of microRNA Expression and Subsequent Colon Cancer Risk. PLOS ONE 2015; 10(12): e0143894 doi: 10.1371/journal.pone.0143894
|
10 |
Wan-ping Wang, Hai-bo Bian, Xia-zhen Wang, Liang Liu, Ding Wei. Association of ERBB4 genetic polymorphism with the risk and prognosis of non-small cell lung cancer in Chinese Han population. Medicine 2021; 100(19): e25762 doi: 10.1097/MD.0000000000025762
|
11 |
Xueren Gao, Moli Huang, Limin Liu, Yan He, Qiang Yu, Hua Zhao, Chunxiao Zhou, Jinkun Zhang, Zhansheng Zhu, Jiao Wan, Xinghong Jiang, Yuzhen Gao, Olga Y. Gorlova. Insertion/Deletion Polymorphisms in the Promoter Region of BRM Contribute to Risk of Hepatocellular Carcinoma in Chinese Populations. PLoS ONE 2013; 8(1): e55169 doi: 10.1371/journal.pone.0055169
|
12 |
Yan Fang, Hongming Yang, Guiming Hu, Jiakun Lu, Jun Zhou, Na Gao, Yuhan Gu, Cunzhen Zhang, Jinhuan Qiu, Yuanyuan Guo, Yunfei Zhang, Qiang Wen, Hailing Qiao. The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03282-1
|